Coen van Hasselt is Professor and Head of the Division of Systems Pharmacology & Pharmacy, which is part of the Leiden Academic Centre for Drug Research (LACDR). I am establishing the Quantitative Pharmacology group, where we aim to develop and apply quantitative pharmacological modeling approaches (pharmacometrics) with systems biology- and bioinformatics based modeling approaches to optimize translational drug development and to support individualized drug treatment. Our group is primarily interested to study the translational and clinical pharmacology of antibiotics and antimicrobial resistance, to optimize antibiotic treatments. Besides computational expertise, we have established an experimental lab to conduct state-of-the-art translational antimicrobial PK/PD experiments. Other therapeutic areas of interest are anti-cancer drug pharmacology and adverse drug reactions. In our work we collaborate extensively with both clinicians and several experimental groups.

More information about Coen van Hasselt

Coen van Hasselt is professor and head of the Division of Systems Pharmacology & Pharmacy, which is part of the Leiden Academic Centre for Drug Research (LACDR). I am establishing the Quantitative Pharmacology group, where we aim to develop and apply quantitative pharmacological modeling approaches (pharmacometrics) with systems biology- and bioinformatics based modeling approaches to optimize  translational drug development and to support individualized drug treatment. Our group is primarily interested to study the translational and clinical pharmacology of antibiotics and antimicrobial resistance, to optimize antibiotic treatments. Besides computational expertise, we have established an experimental lab to conduct state-of-the-art translational antimicrobial PK/PD experiments. Other therapeutic areas of interest are anti-cancer drug pharmacology and adverse drug reactions. In our work we collaborate extensively with both clinicians and several experimental groups.

My PhD degree (2014) was received from the Netherlands Cancer Institute/Utrecht University, with a PhD thesis on novel integrative quantitative pharmacological modeling approaches to optimize drug treatment in oncology. I then was a postdoctoral researcher at the LACDR focusing on antibiotics PK/PD. Between 2015-2017 I was a postdoctoral research fellow at the Ravi Iyengar lab focusing on innovatvie systems pharmacology approaches, at the Icahn School of Mount Sinai, NY, USA, supported by a competetive personal Marie Curie Individual Fellowship.